Generic latanoprost may improve patient adherence with lower costs vs. brand-name agents

Switching from a brand-name prostaglandin analogue to generic latanoprost may improve patient adherence in the treatment of open-angle glaucoma, according to a study presented at the American Glaucoma Society annual meeting.“It is well known that medication adherence is a major challenge for many patients,” Joshua D. Stein, MD, MS, said at the meeting, delivering study results that were published in Ophthalmology. “There are a number of reasons why patients struggle with adherence, one of which is medication costs.”

Exciting products on the horizon for dry eye therapy

The world of ocular surface disease has drawn great attention over the last few years, due mainly to the large expansion of diagnostic technologies to help decipher the dry eye code.Tear osmolarity (TearLab), MMP-9 detection (InflammaDry, RPS), Lipi-View and LipiView II with dynamic meibomian imaging (TearScience), in-office allergy skin testing (Doctors Allergy) and Sjö testing for early disease stage antibody detection (Bausch + Lomb) are just a few of the tools in the ever-expanding diagnostic armamentarium of dry eye disease. Nevertheless, our therapeutic approach to dry eye has been fairly (Read more...)